The current study investigated the hypothesis that the duration of the proinflammatory environment plays a critical role in the brain's response that results in negative consequences on cognition, biochemistry, and pathology. Lipopolysaccharide or artificial cerebrospinal fluid was slowly (250 hg/h) infused into the fourth ventricle of young (3-month-old), adult (9-month-old), or aged (23-month-old) male F-344 rats for 21 or 56 days. The rats were then tested in the water pool task and endogenous hippocampal levels of pro-and anti-inflammatory proteins and genes and indicators of glutamatergic function were determined. The duration of the lipopolysaccharide infusion, compared with the age of the rat, had the greatest effect on (1) spatial working memory; (2) the density and distribution of activated microglia within the hippocampus; and (3) the cytokine protein and gene expression profiles within the hippocampus. The duration-and age-dependent consequences of neuroinflammation might explain why human adults respond positively to anti-inflammatory therapies and aged humans do not.
Introduction
Advanced age and the duration of neuroinflammation might equally contribute to the frequent co-occurrence of Alzheimer's disease (AD) and Parkinson's disease (PD; Aarsland et al., 2001; Akiyama et al., 2000; Hobson and Meara, 2004; Hughes et al., 2000) . Recent reports have shown that the co-occurrence of these disorders increases in a duration-dependent manner from 28% 6 years after diagnosis to approximately 83% 20 years after diagnosis (Hely et al., 2008; Perez et al., 2012) . We and others have speculated that the consequences of neuroinflammation associated with microglial activation, operating across a time scale of decades, are carefully regulated until, because of normal aging, there is a gradual shift to a nonequilibrium state that is permissive for neurodegenerative processes (Colton and Wilcock, 2010; Smith et al., 2012; Wenk and Hauss-Wegrzyniak, 2001 ). Consistent with this hypothesis are epidemiological evidence that very long duration inflammatory diseases in humans, such as atherosclerosis, obesity, diabetes, depression, and periodontitis increase the risk of AD (Andersen et al., 2005; Balakrishnan et al., 2005; Biessels and Kappelle, 2005; Casserly and Topol, 2004; Dowlati et al., 2010; Kamer et al., 2009; Ownby et al., 2006) .
Microglia activation is detectable many years before the onset of neuropathological changes associated with AD and PD and is predictive of later symptom severity, demonstrated by positron emission tomography studies (Cagnin et al., 2006; Gerhard et al., 2006; Imamura et al., 2003) . Microglia can assume various activation states that are associated either with elevations of proinflammatory cytokines and the release of potentially destructive oxidative enzymes or the expression of a cytokine activation profile that sustains repair, recovery, and growth (Colton and Wilcock, 2010; Sudduth et al., 2013) . This spectrum of activation states has been categorized as M1 or M2 in macrophages (Mantovani et al., 2004) . Vulnerable brain regions, particularly the hippocampus, are likely exposed for many decades to a complex and varying blend of microglia in alternative activation states (Bilbo, 2010; Eikelenboom et al., 2010; Heneka et al., 2010; Herrup, 2010; Sudduth et al., 2013) . The current study investigated the differential influence of brain age and the duration of the proinflammatory stimulus on the profile of hippocampal pro-and antiinflammatory genes and proteins, the number of histologically identified activated microglia, and performance in a spatial memory task.
Methods

Experimental design
Young, adult, and aged male F-344 rats received a chronic infusion of lipopolysaccharide (LPS), or its vehicle, into the fourth ventricle for 21 or 56 days and were then evaluated using behavioral, histological, biochemical, and genetic analyses. Multiple counter-balanced iterations of this study were performed so that at the end of the investigation each group contained 11 rats; thus, 132 rats completed all aspects of the investigation.
Subjects
Young (3-month-old), adult (9-month-old), and aged (23-month-old) male F-344 rats (Harlan Sprague-Dawley) were maintained on a 12/12-hour light/dark cycle in a temperature-controlled room (22 C) with free access to food and water and with lights off at 9:00 PM. All rats were sacrificed during the dark phase of the diurnal cycle. Body weights and general health were closely monitored throughout the study. All rats were given health checks, handled on arrival, and allowed at least 1 week to adapt to their new environment before surgery. We certify that the experiments were carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals , revised in 1996. We also certify that the formal approval to conduct the experiments was obtained from the animal subjects review board of Ohio State University.
Surgery
Artificial cerebrospinal fluid (aCSF; 140 mM NaCl, 3.0 mM KCl, 2.5 mM CaCl 2 , 1.0 mM MgCl 2 , and 1.2 mM Na 2 HPO 4 adjusted to pH 7.4) or LPS (0.25 mg/h, 1.66 mg/mL prepared in aCSF; E. coli, serotype 055:B5, TCA extraction; Sigma) were chronically infused via a cannula that was implanted into the fourth ventricle (À2.5 mm AP and À7.0 mm DV relative to lambda) and attached (via Tygon tubing, 0.06 O.D.) to an osmotic minipump (Alzet model 2006; to deliver 0.15 ml/h; Durect Corp, Cupertino, CA, USA) as previously described (Hauss-Wegrzyniak et al., 1998; Marchalant et al., 2007; Rosi et al., 2005) . Calculations using the average fill volume for this pump allows for release of LPS or aCSF for up to 56 days. Postoperative care included lidocaine 1% solution applied to the exposed skin on closure and 2 mL of isotonic saline via subcutaneous injection to prevent dehydration during recovery.
Behavioral testing: water pool task
The rats were handled daily for 5 days before behavioral testing began. Spatial learning ability was assessed for all rats using a 170-cm diameter water pool with gray walls. The water was maintained at room temperature (RT; 21 Ce22 C). The pool was in the center of a room with multiple visual stimuli as distal and proximal cues. The circular escape platform was 10 cm in diameter. For the spatial (hidden platform) version of the water task, a circular escape platform was present in a constant location, submerged 2.5 cm below the water surface. The rats were tracked using Noldus Ethovision 3.1 tracking and analysis system (Noldus, Leesburg, VA, USA).
Each rat performed 6 trials per day for 4 consecutive days (24 trials total), with a 60-minute intertrial interval. The rat was released into the water on each trial from 1 of 7 locations spaced evenly at the side of the pool, which varied so that the rats did not start from any location twice in 1 day. After the rat found the escape platform or swam for a maximum of 60 seconds, it was allowed to remain on the platform for 30 seconds. At the end of the fourth day, the platform was removed and a standard probe trial was conducted. After the probe test, all rats were also tested with the platform raised 2 cm above the surface of the water to control for possible aging or LPS-induced deficits in visual acuity. The effects of aging and/or inflammation were assessed by the comparison of the latency to find the platform.
2.5. Histology 2.5.1. Tissue collection All the rats were deeply anesthetized before sacrifice. Rats used for histology (5 rats per group) were prepared for a transcardiac perfusion with cold saline containing 1 U/mL heparin, followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brains were then postfixed overnight in the same fixative and then stored (4 C) in phosphate-buffered saline (PBS), pH 7.4. Rats used for biochemistry (6 rats per group) from each group were briefly anesthetized and then rapidly decapitated; their hippocampi were quickly dissected on ice. The left and right hippocampi were randomly chosen for either protein or gene expression analyses. The hippocampi were stored at À80 C until processed. Blood was collected during the rapid decapitation procedure. After centrifugation at 4 C for 15 minutes at 2500g, serum was collected and assayed.
Immunocytochemistry
Free-floating coronal sections (40 mm) were obtained using a vibratome from perfused tissues for staining with standard avidin/biotin peroxidase labeling methods. The monoclonal antibody OX-6 (final dilution 1:200; Pharmigen, San Diego, CA, USA) was used to visualize activated microglial cells only. This antibody is directed against the class II major histocompatibility complex (MHC II) antigen, an indicator of activation (Akiyama et al., 2000; . After quenching endogenous peroxidase activity and blocking nonspecific binding, the sections were incubated (4 C) overnight with the primary antibody. Thereafter, the sections were incubated for 1.5 hours at RT with the secondary polyclonal antibody, rat adsorbed biotinylated horse anti-mouse immunoglobulin G (final dilution 1:200; Vector, Burlingame, CA, USA). Sections were then incubated for 1 hour at RT with avidinbiotinylated horseradish peroxidase (Vectastain, ABC kit; Vector). After washing again in PBS, the sections were incubated with 0.05% 3, 3'-diaminobenzidine tetrahydrochloride (Vector) as a chromogen. The reaction was stopped by washing the section with PBS. No staining was detected in the absence of the primary or secondary antibodies. Sections were mounted on slides, air-dried, and coverslipped with cytoseal (Allan Scientific, Kalamazoo, MI, USA) mounting medium. The location of immunohistochemicallydefined cells was examined using light microscopy. Quantification of cell density in the reconstructed hippocampal coronal sections (at least 5 sections from each rat) was assessed with a Nikon 80i documentation system with a DS-5M-L1 digital camera using Elements 3.1 software (Nikon Instruments, Melville, NY, USA) and quantified using MetaMorph imaging software (Universal Image Corporation, West Chester, PA, USA).
Biochemistry
Protein analysis
Frozen (À80 C) hippocampi were placed in a BioPlex Cell Lysis solution (Bio-Rad, Richmond, CA, USA) and total proteins were extracted according to the manufacturer's instructions. Hippocampal levels of tumor necrosis factor (TNF)-a, interleukin (IL)-1a, IL-1b, IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, IL-18 (interferon-g
[INFg]-inducing factor), INFg, and granulocyteemacrophage-stimulating factor (GM-CSF) were quantified simultaneously with a bead-based flow cytometric immunoassay (Bio-Rad; BioPlex Pro Rat Standard, 171-K1002M). Briefly, a mixture of distinct capture beads (fluorescently dyed microspheres) each with a specific spectral address and conjugated to an antibody against 1 of the cytokines already listed were dispensed across a 96-well plate and protected from light. Samples and antigen standards were added in duplicate and incubated for 1 hour at 700 rpm at RT; unbound materials were washed away (3 times). Then, biotinylated detection antibodies directed against each of the proteins were added for 30 minutes at 700 rpm at RT; unbound materials were washed away (3 times). Each well was then incubated for 10 minutes at 700 rpm at RT with a reporter dye, streptavidin-phycoerythrin conjugate, which binds to the detection antibody; unbound materials were washed away (3 times). Each well was then suspended in assay buffer and shaken at 1100 rpm for 30 seconds. Finally, the contents of each well was passed through a dual detection flow cytometer with a classification laser that distinguishes each of the proteins by color of its bound antigen-specific bead and a reporter laser that quantifies each molecule based on the fluorescence of bound antigen-specific streptavidin-phycoerythrin conjugate reporter dye. Values were compared with standard curves; all of the biomarkers were well above the background detection level of the assay. Calculated values were standardized to the total protein content of the homogenate. GM-CSF was examined because it can activate microglia and might play a role in the pathophysiology of AD (Parajuli et al., 2012; Tarkowski et al., 2001) , multiple sclerosis (Carrieri et al., 1998) , and HIV-associated dementia (Perrella et al., 1992) ; expression of the TLR4 gene was examined because its protein is the principle target of LPS (Akashi et al., 2003) and can be upregulated by exposure to GM-CSF (Parajuli et al., 2012) . Total protein was quantified in brain homogenates using the Bio-Rad protein assay. The results are reported as pg/mg of protein.
Real-time polymerase chain reaction messenger RNA analysis
Total RNAs were extracted from hippocampi using Trizol reagent (Life Technologies, Carlsbad, CA, USA) followed by NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany) according to the manufacturers' instructions. Total RNAs (1 mg) from each sample were reverse-transcribed using the iScript reverse transcription Supermix for RT-qPCR (Bio-Rad). Primers were designed for each gene using the PrimerQuest software (Integrated DNA Technologies, Coralville, IA, USA; Table 1 ). Primer alignments were performed using the BLAST database to ensure specificity of primers. Primers and Sso Advanced SYBR Green Supermix (Bio-Rad) were prepared with RNase-free water. For polymerase chain reaction (PCR) amplification, mix (19 mL) was added to RT reaction (1 mL) previously diluted (1:20). Assays were run in triplicate using the CFX96, C1000 Thermal Cycler (Bio-Rad). Amplification conditions were as follows: 95 C for 30 seconds; 40 cycles of PCR (denaturation: 95 C for 5 seconds, annealing/extension: 60 C for 30 seconds), and melting curves. Two negative control samples were run during each quantitative PCR experiment: reaction without the reverse transcription (eRT) to confirm the absence of genomic DNA contamination, and samples with no added cDNA template to prove the absence of primer dimers. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a housekeeping gene. The cycle (Ct) at which expression levels crossed the threshold was normalized to the Ct of the housekeeper GAPDH, producing DCt with arbitrary units of total gene expression. All plates were evaluated with respect to eRT and H 2 O control samples.
Statistical analysis
Statistical analyses were conducted using SigmaStat 12.0 (Systat, San Jose, CA, USA). Analyses of variance were performed followed by Fisher's protected lease significant difference for post hoc comparisons. Graphs are shown with standard error of the mean represented by error bars. Control aCSF is shown in some graphs as 1 collapsed group, but aCSF groups were not collapsed for statistical analysis. A p < 0.05 was considered statistically significant.
Results
Behavior
The latency to find the submerged platform (Fig. 1) was significantly impaired by the age of the rat (F(3,2495) ¼ 140.5; p < 0.001) and LPS treatment (F(1,2495) ¼ 7.2; p ¼ 0.007); furthermore, the response of the rat to LPS was influenced by the age of the rat (p ¼ 0.029) and the duration of the exposure to LPS (p ¼ 0.014). Performance in the probe trial (Fig. 2) was also impaired by the rat's Overall, the age-dependent decline in performance was potentiated by LPS-infusion in a duration-dependent manner in young and middle-aged rats. In contrast, the baseline performance of the aged rats was so poor that the LPS exposure did not worsen performance.
Histology
The increased density of MHC II-immunoreactive (MHC II-IR) microglia (Fig. 3) in the dentate gyrus, CA3, and CA1 regions of the hippocampus was significantly (all F > 25; p < 0.001) influenced by the LPS infusion, the age of the rat, and the duration of the exposure. Furthermore, the interaction between age and LPS treatment was significantly (p < 0.001) dependent on the duration of the LPS infusion.
3.3. Biochemistry 3.3.1. Hippocampal proteins LPS treatment significantly (p < 0.001) increased IL-1a and IL-1b levels (Fig. 4) . In contrast, TNFa, GM-CSF, and IL-13 levels were Water maze performance. The latency to find the submerged platform was significantly influenced by an interaction between the rats' age and the LPS infusion; furthermore, the effects of the rats' age and treatment on performance depended on the duration of the LPS infusion. All young and adult rats had significantly (p < 0.05) shorter latencies to find the submerged platform across testing days. * p < 0.01 versus aCSF-infused rats within the same age group; y p < 0.01, comparing across age groups; # p < 0.01, 3-month-old rats significantly (p < 0.01) influenced by the duration of the LPS infusion. GM-CSF also demonstrated a duration-dependent increase (p ¼ 0.05) in which it was elevated only in aged rats, and only after a 56-day infusion, regardless if LPS or aCSF was infused. The anti-inflammatory cytokine IL-13 was also elevated after 56 days of LPS infusion in young and aged rats only (see Fig. 4 ). Endogenous hippocampal levels of the other biomarkers (i.e., IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, and INFg) were unchanged across all age groups, treatments, and duration of infusion (data not shown).
Serum proteins
Serum levels of IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, GM-CSF, INFg, and TNFa were unchanged across all age and treatment groups (data not shown).
Hippocampal gene expression
LPS exposure significantly (p < 0.03) increased the gene expression of IL-1b, transforming growth factor (TGF)b and the Tolllike receptor type 4 (TLR4) receptor (Fig. 4) . The duration of the LPS infusion had its greatest impact (F > 5, p < 0.02) on fractalkine receptor and TLR4 receptor gene expression whereas the age of the rat had the greatest effect (F > 6; p < 0.01) on fractalkine receptor, TGFb and the TLR4 receptor gene expression. The changes in TGFb levels are similar to those in AD (Rota et al., 2006) . The durationand age-dependent profile of TLR4 gene expression mirrored that of GM-CSF, increasing in aged rats after 56 days of either aCSF or LPS infusion. Proinflammatory TNFa gene expression was significantly increased after 56 days of LPS infusion in young and aged rats, following the same profile of anti-inflammatory IL-13 protein influenced by aging, LPS treatment, and the duration of the LPS infusion. Furthermore, there were significant interactions between the effects of aging and the LPS treatment, aging and the duration of the LPS infusion, and the LPS treatment and its duration. Finally, the interaction between age and LPS treatment depended significantly on the duration of the LPS infusion. * p < 0.01 versus aCSF; # p < 0.01 versus 21 days LPS; y p < 0.01. Abbreviations: aCSF, artificial cerebrospinal fluid; DG, dentate gyrus; LPS, lipopolysaccharide; MHC II-IR, class II major histocompatibility complex-immunoreactive. expression (data not shown). Gene expression of the antiinflammatory cytokine TGFß and the fractalkine receptor were both elevated (p < 0.04) in a duration-dependent manner after LPS infusion of either 21 or 56 days in aged rats. Changes in the expression of glutamate transporter 1 (GLT1), the major glutamate transporter, XcT, a sodium-independent cystine-glutamate transporter, TNFa, fractalkine ligand, and BDNF genes were not statistically significant; their data are not shown.
Discussion
In the current study, we produced a proinflammatory environment in brains of young, adult, and aged male rats and then systematically documented an evolving series of behavioral, biochemical, and gene expression changes induced by the chronic infusion of pM levels of LPS into the fourth ventricle. These changes represent a complex interplay of glia (astrocytes and microglia) and neurons leading to a series of changes that transpire in the presence of continued stimulation of TLR4 receptors on microglia. In the current study, LPS was used as a chemical tool to selectively stimulate the TLR4/CD14 complex expressed by microglia; administered in this fashion, the overall dose of LPS is not sufficient to produce any peripheral manifestations of infectious disease processes (such as elevated serum levels of inflammatory cytokines) or downregulation in TLR4 gene expression in the brain. We have previously documented an array of duration-dependent changes after infusion of LPS in this manner particularly within the hippocampus (Hauss-Wegrzyniak et al., 1998 , 2002 Marchalant et al., 2008 Marchalant et al., , 2009 Rosi et al., 2004 Rosi et al., , 2009 Wenk et al., 2000) .
Hippocampal-dependent spatial learning measured according to performance in the water maze showed a duration-dependent decline in young and middle-aged rats; in contrast, performance of aged rats was not further impaired by the LPS infusion, as compared with the performance of age-matched aCSF-infused rats. Throughout the hippocampus, an increase in the density of MHC II-IR microglia depended on the duration of the LPS infusion and, inversely, the age of the rat. Generally, the number of activated microglia increased in parallel with the infusion duration across all age groups; however, the magnitude of the increase in the number of MHC II-IR microglia was more dynamic in younger rats and diminished in aged rats. Surprisingly, the blunted response to LPS Fig. 4 . Hippocampal cytokines levels (bottom panel) and gene expression (top panel). The infusion of lipopolysaccharide (LPS) into the fourth ventricle significantly increased the protein levels of interleukin (IL)-1a and IL-1b (notice the scale difference for IL-1b). The increased levels of TNFa and IL-13 depended on the duration of the LPS infusion. The increased levels of GM-CSF depended on an interaction between the influences of the LPS treatment and duration and the age of the rat. Hippocampal levels of IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, and INFg were unchanged. The infusion of LPS into the fourth ventricle significantly increased the gene expression of IL-1b, TGFb, and the TLR4 receptor (notice the scale difference for IL-1b). The increased expression of the TLR4 and fractalkine genes depended on the duration of the LPS infusion. The age of the rat was responsible for increased gene expression for CX3CR1, TGFb, and the TLR4 receptor. Expression of GLT1, TNFa, XcT, fractalkine ligand, and BDNF genes were unchanged. All post hoc comparisons p < 0.05: * aCSF versus LPS within respective age group; # LPS 21 days versus 56 days; y versus 3 months old (3mo); AE versus 9 months old (9mo); y AE versus 3 and 9 months old. Abbreviations: aCSF, artificial cerebrospinal fluid; BDNF, brain-derived neurotrophic factor; CX3CR1, chemokine (C-X3-C motif) receptor 1; GLT, glutamate transporter 1; GM-CSF, granulocyteemacrophagestimulating factor; INF, interferon; TGF, transforming growth factor; TLR, Toll-like receptor; TNF, tumor necrosis factor; XcT, cystine/glutamate transporter.
by the aged rat hippocampus occurred in the presence of increased expression of TLR4 suggesting that endotoxin tolerance does not develop in the aged brain. Furthermore, increased TLR4 expression in response to the LPS infusion was only observed in the aged rats and these changes were duration-dependent. Surprisingly, the increased TLR4 expression in response to the LPS infusion in old rats occurred in the presence of significantly fewer indicators of microglial activation. The diminished response might be because of an age-related decline in the number of microglia available for activation; however, significant changes in microglia density do not occur in normal aged rats (Long et al., 1998) . The blunted response of aged rats to LPS might also be because of the aged microglia's impaired ability to regulate its response to inflammogens such as LPS (Cerbai et al., 2012) or mutant proteins such as beta amyloid (Cameron et al., 2012; Cribbs et al., 2012; Flanary et al., 2007; ). An age-related decline in the normal microglia response might also underlie the fact that adult humans and young rodents respond positively to anti-inflammatory therapies (Breitner et al., 2011; Hauss-Wegrzyniak et al., 1999; Leoutsakos et al., 2012) and aged humans and rodents do not (Bachstetter et al., 2012; Breitner et al., 2011; Drye and Zandi, 2012; HaussWegrzyniak et al., 1999) .
Ordinarily, GM-CSF levels are barely detectable in the adult brain (Dame et al., 1999) . However, in the current study, GM-CSF levels increased within the hippocampus in response to prolonged LPS exposure, but only in the aged rats. GM-CSF is a proinflammatory factor released by astrocytes in response to IL-1b or LPS that binds to a specific receptor on microglia leading to upregulation of MHC II expression (Pierson et al., 2012) and TLR4 expression (Parajuli et al., 2012) in young adult rats. GM-CSF can also enhance the LPS-induced nuclear factor kappa light chain enhancer of activated B cells (NF-kB) nuclear translocation and production of IL-1b and TNF-a (Parajuli et al., 2012) . Our results demonstrated that the parallel changes in TLR4 expression and GM-CSF production was significantly influenced by the duration of the neuroinflammatory environment and the age of the rat. Overall, young rats responded with a robust M1-type response similar to that seen during the early stages of AD (Sudduth et al., 2013) , and the aged rats responded with a more complex profile of M1 (IL-1b, IL-1a, CX3CR1, TLR4, TNFa, GM-CSF), M2a (IL-13, MHC II), M2b (MHC II), and M2c (TGFb) biomarkers (Mantovani et al., 2004) . The results of the current study further demonstrated that aged microglia display a blunted upregulation of MHC II expression in response to elevated levels of IL-1b and GM-CSF in response to LPS exposure. The profile of cytokine biomarkers in the aged rats showed a greater response for the markers of alternative activation states, such as TGF-b, IL-13, and CX3CR1; all of which might be expected to mute the microglial response to LPS. Thus, the lack of MHC II expression, typically associated with an M1 or M2b response, might be explained by a greater chronic M2 activation state in response to LPS in the aged rat brain. Our results suggest that chronically elevated levels of GM-CSF in the aged brain might function to accelerate the progression of AD by increasing TLR4 expression on microglia in the absence of any observable changes in MHC II expression by resident microglia. These results suggest that in the aged brain MHC II expression is not a useful indicator of the microglia activation state.
The LPS infusion increased IL-1a in aged rats and IL-1b in all rats. IL-1b gene and protein levels correlated significantly with each other (p < 0.001) and were elevated in aged rats despite the blunted MHC II expression in response to LPS. These robust changes in IL-1a and IL-1b gene expression and protein levels in the brain further highlight the important role played by the IL-1 cytokines in ageassociated cognitive decline (Mrak and Griffin, 2001) , and as the driving force in the phosphorylation of tau (Ghosh et al., 2013) . In contrast to the correlation seen for the ILs, LPS-induced changes in TNFa expression did not correlate with TNFa protein levels in the hippocampus. The current study demonstrated a durationdependent, but not age-dependent, increase in hippocampal TNFa protein levels. The levels of TNFa and its receptor are increased in the AD brain; the TNFa receptor might be necessary for betaeamyloidinduced cell death (Cheng et al., 2010) . TNFa also plays a critical role in neuroplasticity via its interaction with glutamatergic neurotransmission and the role of glutamate in cytotoxicity (Santello and Volterra, 2012) , thus it is not surprising that in the current study TNFa protein levels correlated significantly (p ¼ 0.02) with GLT1, the major glutamate transporter, gene expression. GLT1 is responsible for glutamate clearance in hippocampal tissue and is almost exclusively expressed by astrocytes, particularly perisynaptic astrocytes in regions receiving dense glutamatergic innervation, such as the molecular layer of the dentate gyrus (Lehre et al., 1995) . The absence of a significant increase in GLT1 expression was likely because of the elevated levels of IL-1b (Prow and Irani, 2008) . Microglia and neurons do not generally express GLT1 (Milton et al., 1997) , however, GLT1 is present on the surface of microglia exposed to LPS (Persson et al., 2005) . Consistent with this finding, our flow cytometry investigation found a significant increase in the number of CD11b/c-immunopositive microglia expressing GLT1 protein and TLR4 after chronic exposure to LPS (H.M. Brothers, unpublished observation).
There are 2 competing perspectives on the activation state of aged microglia that are crucial to determine how to reduce the consequences of neuroinflammation: (1) that microglia become primed and more reactive with age (Barrientos et al., 2010; Henry et al., 2009) ; and (2) microglia become senescent and less reactive with age (Flanary et al., 2007; ). The first suggests that immunotherapy should be used to suppress microglia activation in the diseased brain, and the latter proposes that we attempt to augment microglia reactivity and promote their function. Ordinarily the number of MHC II-IR microglia in the hippocampus increases with normal aging, however, in our current and previous studies (Bardou et al., 2012; Hauss-Wegrzyniak et al., 1999) , the number of MHC II-IR microglia was not enhanced by chronic LPS exposure in aged rats. In the current study we found no significant age by treatment interactions that were independent of the influence of duration; thus, overall, our results are consistent with the hypothesis that microglia become senescent and less responsive to pro-and anti-inflammatory molecules.
Our behavioral and biochemical results in aged rats are consistent with those reported previously by Cribbs et al. (2012) , that inflammation-related genes for IL-1b, IL-6, and IL-10, but not TNFa, undergo a progressive activation in the aging human hippocampus; the authors concluded that these changes prime the brain for neurodegenerative cascades, cognitive decline, and progression to AD. In the current study, LPS produced a duration-dependent increase in IL-13 protein levels; IL-13 induces a class of proteindegrading enzymes, known as matrix metalloproteinases that might also contribute to the development of disorders that involve neuroinflammation such as amyotrophic lateral sclerosis (Shi et al., 2007) , PD, and multiple sclerosis (Kim and Joh, 2012) , and the degeneration of hippocampal neurons in the presence of beta amyloid (Nam et al., 2012) . It remains unanswered whether similar inflammatory events cause, or result from, the neurodegeneration that leads to these degenerative disorders in aging humans.
Overall, the current results emphasize the critical role of the duration of the pro-inflammatory challenge initiated by mutant proteins, disease, or injury. We speculate that an uncontrolled proinflammatory environment could drive a self-propagating cycle in which abnormal cellular responses promulgate the release of M1 and M2 mediators, such as seen in the current study, which in turn might exacerbate local neuronal injury within discrete brain regions leading to impaired cognition (Mantovani et al., 2004; Sudduth et al., 2013) .
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